CVS Health Co. (NYSE:CVS) Position Increased by Moody National Bank Trust Division

Moody National Bank Trust Division lifted its position in CVS Health Co. (NYSE:CVS – Get Rating) by 1.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 31,653 shares of the pharmacy operator’s stock after acquiring an additional 370 shares during the period. Moody National Bank Trust Division’s holdings in CVS Health were worth $2,949,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in CVS. Diversified Trust Co grew its stake in CVS Health by 1.0% during the 3rd quarter. Diversified Trust Co now owns 14,899 shares of the pharmacy operator’s stock valued at $1,421,000 after acquiring an additional 145 shares in the last quarter. Carnegie Capital Asset Management LLC boosted its holdings in shares of CVS Health by 28.9% during the third quarter. Carnegie Capital Asset Management LLC now owns 55,867 shares of the pharmacy operator’s stock worth $5,328,000 after purchasing an additional 12,527 shares during the period. Bond & Devick Financial Network Inc. increased its stake in CVS Health by 1.9% in the 3rd quarter. Bond & Devick Financial Network Inc. now owns 10,820 shares of the pharmacy operator’s stock valued at $1,032,000 after buying an additional 200 shares during the period. Royal London Asset Management Ltd. lifted its position in CVS Health by 1.3% in the 2nd quarter. Royal London Asset Management Ltd. now owns 470,446 shares of the pharmacy operator’s stock worth $43,601,000 after buying an additional 6,045 shares in the last quarter. Finally, Ritholtz Wealth Management boosted its stake in shares of CVS Health by 107.8% during the 3rd quarter. Ritholtz Wealth Management now owns 26,627 shares of the pharmacy operator’s stock valued at $2,539,000 after buying an additional 13,813 shares during the period. Hedge funds and other institutional investors own 77.29% of the company’s stock.

Analysts Set New Price Targets

CVS has been the subject of several recent research reports. Jefferies Financial Group increased their price objective on CVS Health from $130.00 to $143.00 and gave the stock a “buy” rating in a report on Thursday, February 9th. Wells Fargo & Company lowered their price target on CVS Health from $106.00 to $101.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 3rd. StockNews.com began coverage on shares of CVS Health in a research report on Thursday. They set a “buy” rating on the stock. Credit Suisse Group boosted their target price on shares of CVS Health from $117.00 to $125.00 and gave the stock an “outperform” rating in a research report on Monday, November 21st. Finally, Morgan Stanley raised their price target on shares of CVS Health from $119.00 to $120.00 and gave the company an “overweight” rating in a report on Friday, January 13th. Three investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $119.65.

CVS Health Stock Performance

Shares of NYSE:CVS traded down $1.46 during midday trading on Friday, hitting $74.37. The company’s stock had a trading volume of 16,807,803 shares, compared to its average volume of 9,656,588. CVS Health Co. has a fifty-two week low of $73.91 and a fifty-two week high of $109.69. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.67 and a current ratio of 0.94. The stock has a market capitalization of $95.50 billion, a price-to-earnings ratio of 23.84, a PEG ratio of 1.17 and a beta of 0.65. The stock’s 50 day simple moving average is $85.40 and its 200 day simple moving average is $93.04.

CVS Health (NYSE:CVS – Get Rating) last issued its quarterly earnings results on Wednesday, February 8th. The pharmacy operator reported $1.99 EPS for the quarter, topping the consensus estimate of $1.92 by $0.07. CVS Health had a return on equity of 15.75% and a net margin of 1.29%. The company had revenue of $83.85 billion for the quarter, compared to the consensus estimate of $76.37 billion. During the same period in the previous year, the business posted $1.98 EPS. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. As a group, research analysts anticipate that CVS Health Co. will post 8.84 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, May 1st. Shareholders of record on Friday, April 21st will be issued a $0.605 dividend. This represents a $2.42 dividend on an annualized basis and a yield of 3.25%. The ex-dividend date of this dividend is Thursday, April 20th. CVS Health’s dividend payout ratio (DPR) is presently 77.56%.

CVS Health Company Profile

(Get Rating)

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.